CHOICES IN ONCOLOGY - FACTORS THAT INFLUENCE PATIENTS TREATMENT PREFERENCE

被引:35
作者
KIEBERT, GM
STIGGELBOUT, AM
KIEVIT, J
LEER, JWH
VANDEVELDE, CJH
DEHAES, HJCJM
机构
[1] MED DECIS MAKING UNIT,DEPT SURG,2300 RC LEIDEN,NETHERLANDS
[2] UNIV AMSTERDAM,DEPT MED PSYCHOL,AMSTERDAM,NETHERLANDS
关键词
CANCER; TREATMENT PREFERENCE; QALY; TRADE-OFF;
D O I
10.1007/BF00435382
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Medical treatment of cancer often entails a trade-off between outcomes of two different attributes: quality of life (QOL) and length of life (LL). This process of weighing advantages and disadvantages seems to be influenced by different factors. The main purposes of this study were (a) to investigate the relative importance of different factors on the trade-off and (b) to explore the relationship between these importance ratings and personal characteristics. We asked 199 patients with cancer to indicate to what degree they consider a number of factors to be of importance if they had to choose between two treatment modalities that differ in their expected outcomes concerning OOL and LL. The seven factors were their age at the time of decision, having a partner, having children, inability to work due to side-effects of the treatment, the nature of the side-effects, disease-related life expectancy and baseline OOL. The results indicate that six of the seven factors were of considerable to great importance when a treatment choice had to be made. The negative effects of treatment on the ability to work did not seem to be a very important consideration. Patient age and education were positively associated with importance ratings.
引用
收藏
页码:175 / 182
页数:8
相关论文
共 26 条
[1]   LATE EFFECTS OF ADJUVANT CHEMOTHERAPY AND POSTOPERATIVE RADIOTHERAPY ON QUALITY-OF-LIFE AMONG BREAST-CANCER PATIENTS [J].
BERGLUND, G ;
BOLUND, C ;
FORNANDER, T ;
RUTQVIST, LE ;
SJODEN, PO .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (09) :1075-1081
[2]   ON THE RECEIVING END PATIENT PERCEPTION OF THE SIDE-EFFECTS OF CANCER-CHEMOTHERAPY [J].
COATES, A ;
ABRAHAM, S ;
KAYE, SB ;
SOWERBUTTS, T ;
FREWIN, C ;
FOX, RM ;
TATTERSALL, MHN .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1983, 19 (02) :203-208
[3]  
DANFORD DA, 1990, JAMA-J AM MED ASSOC, V264, P2503, DOI 10.1001/jama.1990.03450190032017
[4]   SHOULD QALYS BE PROGRAM-SPECIFIC [J].
DONALDSON, C ;
ATKINSON, A ;
BOND, J ;
WRIGHT, K .
JOURNAL OF HEALTH ECONOMICS, 1988, 7 (03) :239-257
[5]   METHODOLOGY FOR MEASURING HEALTH-STATE PREFERENCES .4. PROGRESS AND A RESEARCH AGENDA [J].
FROBERG, DG ;
KANE, RL .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1989, 42 (07) :675-685
[6]   ADJUVANT THERAPY OF BREAST-CANCER [J].
GOLDHIRSCH, A ;
GELBER, RD ;
CASTIGLIONE, M .
EUROPEAN JOURNAL OF CANCER, 1991, 27 (03) :389-399
[7]   A COST UTILITY ANALYSIS OF MAMMOGRAPHY SCREENING IN AUSTRALIA [J].
HALL, J ;
GERARD, K ;
SALKELD, G ;
RICHARDSON, J .
SOCIAL SCIENCE & MEDICINE, 1992, 34 (09) :993-1004
[8]  
KAPLAN RM, 1990, JAMA-J AM MED ASSOC, V264, P2502, DOI 10.1001/jama.1990.03450190032016
[9]   EFFECT OF PERIOPERATIVE CHEMOTHERAPY ON THE QUALITY-OF-LIFE OF PATIENTS WITH EARLY BREAST-CANCER [J].
KIEBERT, GM ;
DEHAES, JHCJM ;
KIEVIT, J ;
VANDEVELDE, CJH .
EUROPEAN JOURNAL OF CANCER, 1990, 26 (10) :1038-1042
[10]  
LAPUMA J, 1990, JAMA-J AM MED ASSOC, V264, P2503